Nisa Investment Advisors, LLC Exelixis, Inc. Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 4,890 shares of EXEL stock, worth $175,697. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,890

Previous 5,025 2.69%

Holding current value

$175,697

Previous $112,000 12.5%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$21.96 - $27.6 $2,964 - $3,726	-135 Reduced 2.69%	4,890 $126,000
Q2 2024 Jul 19, 2024	SELL	$20.34 - $23.73 $765,882 - $893,529	-37,654 Reduced 88.23%	5,025 $112,000
Q1 2024 May 01, 2024	BUY	$20.17 - $23.93 $696,651 - $826,518	34,539 Added 424.31%	42,679 $1.01 Million
Q4 2023 Jan 25, 2024	BUY	$19.25 - $24.13 $73,150 - $91,694	3,800 Added 87.56%	8,140 $195,000
Q1 2023 May 02, 2023	SELL	$16.3 - $19.41 $443,702 - $528,359	-27,221 Reduced 86.25%	4,340 $84,000
Q4 2022 Feb 02, 2023	BUY	$14.96 - $17.39 $431,012 - $501,023	28,811 Added 1047.67%	31,561 $506,000
Q3 2022 Nov 07, 2022	SELL	$15.68 - $22.27 $131,241 - $186,399	-8,370 Reduced 75.27%	2,750 $43,000
Q1 2022 Apr 29, 2022	SELL	$17.03 - $22.67 $63,334 - $84,309	-3,719 Reduced 25.06%	11,120 $252,000
Q4 2021 Feb 03, 2022	SELL	$15.84 - $21.88 $55,107 - $76,120	-3,479 Reduced 18.99%	14,839 $269,000
Q3 2021 Oct 18, 2021	SELL	$16.3 - $21.14 $69,356 - $89,950	-4,255 Reduced 18.85%	18,318 $387,000
Q4 2020 Jan 25, 2021	BUY	$18.39 - $24.8 $109,622 - $147,832	5,961 Added 35.88%	22,573 $453,000
Q3 2020 Oct 20, 2020	SELL	$20.67 - $26.94 $114,305 - $148,978	-5,530 Reduced 24.98%	16,612 $406,000
Q2 2020 Jul 27, 2020	BUY	$16.46 - $27.42 $150,724 - $251,084	9,157 Added 70.52%	22,142 $526,000
Q1 2020 Apr 17, 2020	BUY	$14.46 - $21.8 $12,652 - $19,075	875 Added 7.23%	12,985 $224,000
Q4 2019 Jan 17, 2020	BUY	$15.15 - $18.89 $44,692 - $55,725	2,950 Added 32.21%	12,110 $213,000
Q3 2019 Oct 17, 2019	BUY	$17.68 - $22.65 $161,948 - $207,474	9,160 New	9,160 $162,000
Q2 2019 Jul 12, 2019	SELL	$18.93 - $24.75 $49,218 - $64,350	-2,600 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$19.6 - $24.76 $50,960 - $64,376	2,600 New	2,600 $62,000
Q4 2017 Jan 12, 2018	SELL	$24.23 - $30.93 $5,088 - $6,495	-210 Closed	0 $0
Q3 2017 Oct 13, 2017	BUY	$23.35 - $29.24 $4,903 - $6,140	210	210 $5,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Exelixis, Inc. Transaction History